DE471794T1 - Antivirale therapie unter verwendung von thiazin- und xanthenfarbstoffen. - Google Patents

Antivirale therapie unter verwendung von thiazin- und xanthenfarbstoffen.

Info

Publication number
DE471794T1
DE471794T1 DE199090909103T DE90909103T DE471794T1 DE 471794 T1 DE471794 T1 DE 471794T1 DE 199090909103 T DE199090909103 T DE 199090909103T DE 90909103 T DE90909103 T DE 90909103T DE 471794 T1 DE471794 T1 DE 471794T1
Authority
DE
Germany
Prior art keywords
thiazine
dyes
xanthene dyes
antiviral therapy
dye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE199090909103T
Other languages
English (en)
Inventor
F. Raymond Decatur Ga 30033 Us Schinazi
A. Robert Oklahoma City Ok 73120 Us Floyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OKLAHOMA MEDICAL RESEARCH FOUNDATION OKLAHOMA OKLA US
SCHINAZI RAYMOND F DECATUR GA US
Original Assignee
OKLAHOMA MEDICAL RESEARCH FOUNDATION OKLAHOMA OKLA US
SCHINAZI RAYMOND F DECATUR GA US
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996594&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE471794(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by OKLAHOMA MEDICAL RESEARCH FOUNDATION OKLAHOMA OKLA US, SCHINAZI RAYMOND F DECATUR GA US filed Critical OKLAHOMA MEDICAL RESEARCH FOUNDATION OKLAHOMA OKLA US
Publication of DE471794T1 publication Critical patent/DE471794T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE199090909103T 1989-05-11 1990-05-11 Antivirale therapie unter verwendung von thiazin- und xanthenfarbstoffen. Pending DE471794T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35038389A 1989-05-11 1989-05-11
US38900789A 1989-08-03 1989-08-03
PCT/US1990/002659 WO1990013296A1 (en) 1989-05-11 1990-05-11 Antiviral therapy using thiazine and xanthene dyes

Publications (1)

Publication Number Publication Date
DE471794T1 true DE471794T1 (de) 1992-07-23

Family

ID=26996594

Family Applications (2)

Application Number Title Priority Date Filing Date
DE199090909103T Pending DE471794T1 (de) 1989-05-11 1990-05-11 Antivirale therapie unter verwendung von thiazin- und xanthenfarbstoffen.
DE69028775T Revoked DE69028775T2 (de) 1989-05-11 1990-05-11 Antivirale therapie unter verwendung von thiazin- und xanthenfarbstoffen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69028775T Revoked DE69028775T2 (de) 1989-05-11 1990-05-11 Antivirale therapie unter verwendung von thiazin- und xanthenfarbstoffen

Country Status (8)

Country Link
EP (1) EP0471794B1 (de)
JP (2) JPH07119173B2 (de)
AT (1) ATE143596T1 (de)
CA (1) CA2055463C (de)
DE (2) DE471794T1 (de)
DK (1) DK0471794T3 (de)
ES (1) ES2032742T3 (de)
WO (1) WO1990013296A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6090043A (ja) * 1983-10-21 1985-05-21 Nippon Shokubai Kagaku Kogyo Co Ltd 窒素酸化物浄化用触媒
DE3930510A1 (de) * 1989-09-13 1991-03-21 Blutspendedienst Dt Rote Kreuz Verfahren zur inaktivierung von viren in blut und blutprodukten
US5545516A (en) * 1990-05-01 1996-08-13 The American National Red Cross Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light
WO1991016911A1 (en) * 1990-05-01 1991-11-14 The American National Red Cross Decontamination of whole blood and cellular components by phenthiazin-5-ium-dyes plus light
US6207107B1 (en) 1992-10-05 2001-03-27 Baxter International Inc. Steam sterilizable system for inactivating viral contaminants in body fluids
US5660731A (en) * 1994-11-08 1997-08-26 Pall Corporation Filter for separating photoactive agent
AT406778B (de) * 1996-04-09 2000-09-25 Immuno Ag Verfahren zur desintegration von nucleinsäuren und herstellung von qualitätsgesicherten biologischen produkten
US5935581A (en) * 1996-07-24 1999-08-10 Kapadia; Govind J. Inhibitory effects of synthetic and natural colorants on carcinogenesis
US8974363B2 (en) 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
US6248733B1 (en) 1998-01-09 2001-06-19 3M Innovative Properties Company Method for limiting the growth of microorganisms using metal-containing compounds
US8557298B2 (en) 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
US6610436B1 (en) 1998-09-11 2003-08-26 Gore Enterprise Holdings Catalytic coatings and fuel cell electrodes and membrane electrode assemblies made therefrom
ES2310521T3 (es) 1999-08-13 2009-01-16 Provectus Pharmatech, Inc. Medicamentos topicos mejorados y metodos que permiten el tratamiento de enfermedades de manera fotodinamica.
US6432396B1 (en) 2000-07-06 2002-08-13 3M Innovative Properties Company Limiting the presence of microorganisms using polymer-bound metal-containing compositions
AU2004295148A1 (en) * 2003-11-28 2005-06-16 Photopharmica Limited Developments in biologically active methylene blue derivatives (2)
US20050192267A1 (en) * 2004-02-20 2005-09-01 Hofmann Robert F. Use of targeted oxidative therapeutic formulation in treatment of viral diseases
CN101084204B (zh) * 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
PL2322517T3 (pl) * 2004-09-23 2019-09-30 Wista Laboratories Ltd. Sposoby syntezy chemicznej i oczyszczania związków diaminofenotiazyniowych, w tym chlorku metylotioniny (MTC)
US20060188866A1 (en) * 2005-02-18 2006-08-24 Children's Hospital Oakland Research Institute Diaminophenothiazine compositions and uses thereof
FR2899088B1 (fr) * 2006-03-31 2008-06-27 Mauna Kea Technologies Soc Par "microscopie de fluorescence fibree a base de bleu de methylene."
US8785434B2 (en) 2010-04-30 2014-07-22 Prosetta Antiviral Inc. Antiviral compounds
EP2699241B1 (de) 2011-04-20 2016-07-27 Prosetta Antiviral Inc. Antivirale verbindungen
US11938182B2 (en) 2020-03-26 2024-03-26 Provectus Pharmatech, Inc. Halogenated xanthenes as vaccine adjuvants
MX2022011765A (es) * 2020-03-26 2022-11-09 Provectus Pharmatech Inc Usos novedosos de xantenos halogenados en oncologia y virologia.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA993795A (en) * 1970-12-10 1976-07-27 Richardson-Merrell (Canada) Ltd. Antiviral compositions containing bis-basic ethers and thioethers of xanthene and xanthen-9-ones and methods of treating viruses therewith
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
DE3341001A1 (de) * 1983-11-12 1985-05-23 Krause, Hans Jürgen Nanopartikel aus bioabbaubarem, synthetischem material, verfahren zu deren herstellung und ihre anwendung

Also Published As

Publication number Publication date
DE69028775D1 (de) 1996-11-07
WO1990013296A1 (en) 1990-11-15
EP0471794A1 (de) 1992-02-26
JPH07119173B2 (ja) 1995-12-20
EP0471794B1 (de) 1996-10-02
DK0471794T3 (da) 1996-11-18
ES2032742T3 (es) 1997-02-01
CA2055463C (en) 1997-09-30
JPH08151327A (ja) 1996-06-11
DE69028775T2 (de) 1997-05-07
ATE143596T1 (de) 1996-10-15
ES2032742T1 (es) 1993-03-01
CA2055463A1 (en) 1990-11-12
EP0471794A4 (en) 1992-05-06
JP2700126B2 (ja) 1998-01-19
JPH04507403A (ja) 1992-12-24

Similar Documents

Publication Publication Date Title
DE69028775D1 (de) Antivirale therapie unter verwendung von thiazin- und xanthenfarbstoffen
DE69029528T2 (de) Verwendung von funkionellen Derivaten des Interzellulär-Adhäsions-Moleküls ICAM-1 in einer Antivirus-Therapie
ES8705764A1 (es) Procedimiento fotodinamico de inactivacion de virus
DK214687D0 (da) Thienopyrimidin-2,4-dionderivater samt mellempro- dukter ved fremstillingen deraf
ATE68349T1 (de) Medizinische verwendung von nukleosiden.
PT89838A (pt) Processo para a preparacao de agente terapeutico susceptivel de formar um complexo com glicoproteina de involucro de virus de imunodeficiencia humana
DE3785684T2 (de) Pyrrolidinamid-Derivate von Acylaminosäure, pharmazeutische Zusammensetzung und Verwendung.
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
DE3785717D1 (de) Mehrfach-pulsverfahren und geraet angewendet in der oximetrie.
DE3770085D1 (de) Cyclodextrinclathrate von carbacyclinderivaten und ihre verwendung als arzneimittel.
DE68923035T2 (de) Nachweis von Lanthanid-markierte Nukleotide mittels zeitgelöster Fluorometrie.
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
DE69033636D1 (de) Verwendung von 4-Acyloxychinolin-Derivate als Insektizide und Akarizide
NO893504L (no) Fremgangsmaate for fremstilling av transdermalt anvendbarefarmasoeytiske preparater med steroliner og/eller spiroketaliner.
FI901879A0 (fi) Foerfarande foer producering av naturligt hiv-gp160.
ATE59778T1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
DE3750756D1 (de) Ausführung von Fehlererkennung unter Verwendung eines ungebrauchten Modulo-m-Kodes.
DE3888727D1 (de) Verwendung von Äthylamin-Derivaten als antihypertensive Wirkstoffe.
DE3880533D1 (de) Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole.
IT1225262B (it) Metodo per la sensibilizzazione di piccoli animali all'infezione da virus dell'immunodeficienza umana (hiv)
ATA264387A (de) Pharmazeutische verwendung von phenoxypentyloxy-3,4-dihydro-2h-1-benzopyranderivaten
DE68905875T2 (de) Anti-hiv-wirkung von bu-3608.
RU98109354A (ru) Способ подавления репродукции вируса иммунодефицита человека
ATA263987A (de) Pharmazeutische verwendung von phenoxypentyloxy-3,4-dihydro-2h-1-benzopyrander vaten